Ester to Amide Switch Peptides Provide a Simple Method for Preparing Monomeric Islet Amyloid Polypeptide under Physiologically Relevant Conditions and Facilitate Investigations of Amyloid Formation

被引:29
作者
Cao, Ping [1 ]
Raleigh, Daniel P. [1 ,2 ,3 ]
机构
[1] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Grad Program Biochem & Struct Biol, Stony Brook, NY 11794 USA
[3] SUNY Stony Brook, Grad Program Biophys, Stony Brook, NY 11794 USA
关键词
BETA-CELLS; IN-VITRO; FIBRILLOGENESIS; PURIFICATION; SPECTROSCOPY; MECHANISM; FIBRILS; INSULIN; DISEASE; PROTEIN;
D O I
10.1021/ja910763m
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A major issue in studies of amyloid formation is the difficulty of preparing the polypeptide of interest in an initially monomeric state under physiologically relevant conditions. This is particularly problematic for polypeptides which are natively unfolded in their unaggregated state, and perhaps the most challenging such system is islet amyloid polypeptide (Amylin), the causative agent of amyloid formation in type-2 diabetes. Preparation of islet amyloid polypeptide with the Ser-19 Ser-20 amide bond replaced by an ester circumvents these problems. The modified peptide is unstructured and monomeric at slightly acidic pH's as judged by analytical ultracentrifugation, gel filtration, dynamic light scattering, and CD. A rapid pH jump leads to deprotonation of the Ser-20 amide group, and a subsequent rapid O to N acyl shift regenerates normal human islet amyloid polypeptide. The half time, t(1/2), for the conversion to normal islet amyloid polypeptide is 70 s at pH 7.4. The amyloid fibrils which are formed by the regenerated islet amyloid polypeptide are indistinguishable from those formed by the wild type polypeptide. The approach allows studies of amyloid formation by islet amyloid polypeptide to be carried out from a well-defined, physiologically relevant starting state in the absence of denaturants or organic cosolvents.
引用
收藏
页码:4052 / +
页数:4
相关论文
共 21 条
[1]   Recovery and purification of highly aggregation-prone disulfide-containing peptides: Application to islet amyloid polypeptide [J].
Abedini, A ;
Singh, G ;
Raleigh, DP .
ANALYTICAL BIOCHEMISTRY, 2006, 351 (02) :181-186
[2]   The role of His-18 in amyloid formation by human islet amyloid polypeptide [J].
Abedini, A ;
Raleigh, DP .
BIOCHEMISTRY, 2005, 44 (49) :16284-16291
[3]   EFFECT OF PH AND INSULIN ON FIBRILLOGENESIS OF ISLET AMYLOID POLYPEPTIDE IN-VITRO [J].
CHARGE, SBP ;
DEKONING, EJP ;
CLARK, A .
BIOCHEMISTRY, 1995, 34 (44) :14588-14593
[4]   Protein misfolding, functional amyloid, and human disease [J].
Chiti, Fabrizio ;
Dobson, Christopher M. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :333-366
[6]   PURIFICATION AND CHARACTERIZATION OF A PEPTIDE FROM AMYLOID-RICH PANCREASES OF TYPE-2 DIABETIC-PATIENTS [J].
COOPER, GJS ;
WILLIS, AC ;
CLARK, A ;
TURNER, RC ;
SIM, RB ;
REID, KBM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8628-8632
[7]   Switch-peptides:: Controlling self-assembly of amyloid β-derived peptides in vitro by consecutive triggering of acyl migrations [J].
Dos Santos, S ;
Chandravarkar, A ;
Mandal, B ;
Mimna, R ;
Murat, K ;
Saucède, L ;
Tella, P ;
Tuchscherer, G ;
Mutter, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (34) :11888-11889
[8]   Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils [J].
Higham, CE ;
Jaikaran, ETAS ;
Fraser, PE ;
Gross, M ;
Clark, A .
FEBS LETTERS, 2000, 470 (01) :55-60
[9]   The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles [J].
Janson, J ;
Ashley, RH ;
Harrison, D ;
McIntyre, S ;
Butler, PC .
DIABETES, 1999, 48 (03) :491-498
[10]   EVIDENCE OF COSECRETION OF ISLET AMYLOID POLYPEPTIDE AND INSULIN BY BETA-CELLS [J].
KAHN, SE ;
DALESSIO, DA ;
SCHWARTZ, MW ;
FUJIMOTO, WY ;
ENSINCK, JW ;
TABORSKY, GJ ;
PORTE, D .
DIABETES, 1990, 39 (05) :634-638